Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Light-Activated Antimicrobial Surface Also Works in the Dark

Published: Tuesday, March 25, 2014
Last Updated: Tuesday, March 25, 2014
Bookmark and Share
The new antibacterial material, developed by researchers at UCL, has potential for cutting hospital acquired infections.

The combination of two simple dyes with nanoscopic particles of gold is deadly to bacteria when activated by light - even under modest indoor lighting. And in a first for this type of substance, it also shows impressive antibacterial properties in total darkness.

The research, from by Sacha Noimark and Ivan Parkin (both UCL Chemistry) and Elaine Allan (UCL Eastman Dental Institute), is published today in the journal Chemical Science.

Hospital-acquired infections are a major issue for modern medicine, with pathogens like methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile (C. diff) getting extensive publicity. Although medical establishments have stringent cleaning policies, insist on frequent hand-washing by staff, and have powerful drugs at their disposal, it is difficult to eliminate these infections unless you can make the hospital environment more hostile to microbes. Surfaces, such as door handles, medical equipment, keyboards, pens and so on are an easy route for germs to spread, even onto freshly-cleaned hands.

One possible solution to this is to develop alternative strategies such as antibacterial coatings that make surfaces less accommodating to germs. These surfaces are not like antibacterial fluids that just wash away - the goal is to make a surface which is intrinsically deadly to harmful bacteria.

 “There are certain dyes that are known to be harmful to bacteria when subjected to bright light,” explains the study’s corresponding author Ivan Parkin (Head of UCL Chemistry). “The light excites electrons in them, promoting the dye molecules to an excited triplet state and ultimately produces highly reactive oxygen radicals that damage bacteria cell walls. Our project tested new combinations of these dyes along with gold nanoparticles, and simplified ways of treating surfaces which could make the technology easier and cheaper to roll out.”

The team, tested several different combinations of the dyes crystal violet (already used to treat staph infections), methylene blue and nanogold, deposited on the surface of silicone. This flexible rubbery substance is widely used as a sealant, a coating and to build medical apparatus such as tubes, catheters and gaskets, and can also be used as protective casings for things like keyboards and telephones.

While work to create antimicrobial surfaces in the past has often concentrated on complex ways of bonding dyes to the surface, this study took a simpler approach. The researchers used an organic solvent to swell the silicone, allowing the methylene blue and gold nanoparticles to diffuse through the polymer. They then dipped the silicone into a crystal violet solution to form a thin dye layer at the polymer surface.

In their tests, in which infected surfaces were subjected to light levels similar to those measured in hospital buildings, surfaces treated with a combination of crystal violet, methylene blue and nanogold showed the most potent bactericidal effect ever observed in such a surface. Moreover, the treatment did not significantly change the properties of the silicone (for instance, how water repellent it is), and the coating was not affected by rubbing with alcohol wipes, meaning it can stand up to the repeated cleaning that goes on in hospitals, without being worn off.

“Despite contaminating the surface with far more bacteria than you would ever see in a hospital setting, placed under a normal fluorescent light bulb, the entire sample was dead in three to six hours, depending on the type of bacteria,” says the paper’s lead author, Sacha Noimark. “That was an excellent result, but the bigger surprise was the sample which we left in the dark. That sample too showed significant reductions in bacterial load, albeit over longer timescales of about three to eighteen hours. The precise mechanism by which this dark-kill works is not yet clear, though.” 

This is the first time a light-activated antimicrobial surface has had any kind of effect in the dark. This, along with its unprecedented performance under hospital lighting conditions, and relatively simple and cost-effective manufacture, means that the technology is extremely promising for future applications.

The team have been granted a patent on the formulation. The work was sponsored through the UCL M3S engineering doctorate centre and co-funded by Ondine Biopharma.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Variant of Streptococcal Bacteria
Scientists have discovered a new variant of streptococcal bacteria that has contributed to a rise in disease cases in the UK over the last 17 years.
Wednesday, July 15, 2015
Smoking Signs
Research reveals epigenetic alterations caused by smoking.
Wednesday, May 20, 2015
New Biomarkers To Spot Pancreatic Cancer Early
A combination of two biomarkers can identify pre-clinical pancreatic cancer.
Thursday, February 05, 2015
Autolus Launches With £30m Investment
UCL cancer immunotherapy company, Autolus is launches to develop T-cell therapies for haematological and solid tumours.
Thursday, January 22, 2015
Raman Spectroscopy May Enable Non-Invasive Diagnosis of Bone Diseases
Detection of a genetic ‘brittle bone’ disease known as Osteogenesis Imperfecta (OI) is possible by simply scanning a patient’s limbs.
Wednesday, December 03, 2014
UCL Research Helps Paralyzed Man to Recover Function
UCL scientists develop a pioneering cell transplantation treatment.
Tuesday, October 28, 2014
Designer Piercings: New Membrane Pores with DNA Nanotechnology
A new way to build membrane-crossing pores, using Lego-like DNA building blocks, has been developed by scientists.
Tuesday, November 12, 2013
100,000 UK Volunteers Invited to Donate Genome to Science
The search for UK volunteers willing to donate their genome and health data to science has begun with the launch today of the Personal Genome Project UK.
Tuesday, November 12, 2013
New Director Named for Leading HIV Research Centre in South Africa
Professor Pillay will take up his post on secondment from UCL on 1 November 2013.
Wednesday, September 04, 2013
Scientists Transplant Photoreceptors from Retina Grown ‘In a Dish’
Study suggests that embryonic stem cells provide unlimited supply of healthy photoreceptors to treat blindness in humans.
Tuesday, July 23, 2013
How 'Obesity Gene' Triggers Weight Gain
Researchers have discovered why people with a variation of the FTO gene that affects one in six of the population are 70 per cent more likely to become obese.
Wednesday, July 17, 2013
'Chase and Run' Cell Movement Mechanism Explains Metastasis
A mechanism that cells use to group together and move around the body has been described for the first time by scientists at UCL.
Thursday, June 20, 2013
More Than Two Hundred Genes Identified for Crohn’s Disease
More than two hundred gene locations have now been identified for the chronic bowel condition Crohn's Disease, in a study that analysed the entire human genome.
Wednesday, December 19, 2012
Scientists Uncover Achilles Heel of Chronic Inflammatory Pain
BBSRC funded discovery could lead to a brand new class of drugs to treat chronic pain caused by inflammatory conditions.
Thursday, August 19, 2010
Balancing Protein Intake, not Cutting Calories, may be Key to Long Life
Getting the correct balance of proteins in diet is more important for healthy ageing than reducing calories, UCL research suggests.
Friday, December 04, 2009
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!